SEC 13F Intelligence

Foresite Capital Management IV, LLC / LYEL

Foresite Capital Management IV, LLC’s Lyell Immunopharma Inc Position

Does Foresite Capital Management IV, LLC own Lyell Immunopharma Inc (LYEL)? Yes — 800.4K shares worth $16M (+6.77% of its 13F portfolio) as of Q1 2026.

Position Value
$16M
Q1 2026
Shares
800.4K
% of Portfolio
+6.77%
Quarters Held
4
currently held

Position History LYEL

Reported value by quarter
Q2 ’25: $7MQ2 ’25Q3 ’25: $13MQ3 ’25Q4 ’25: $25MQ4 ’25Q1 ’26: $16MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026800.4K$16M+6.77%
Q4 2025800.4K$25M+10.72%
Q3 2025800.4K$13M+7.12%
Q2 2025800.4K$7M+5.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of LYEL.